Vinayak Kumar

Vinayak Kumar

Auto-generated profile, based on publicly available information

Vinayak Kumar

From the Departments of Radiology (P.S.R.) and Cardiology (V.K., T.G.A.), Mayo Clinic, 200 1st Street SW, Rochester, MN 55905; Department of Radiology, Hospital Clinic de Barcelona, Barcelona, Spain (B.D.X); Department of Biomedical Sciences, Humanitas University, Rita Levi Montalcini Pieve Emanuele (Milan) Italy and RCCS Humanitas Research Hospital, Rozzano, Milan, Italy (M.F.); and Cardiothoracic Imaging Unit, HT Médica, Hospital San Juan de Dios, Córdoba, Spain (J.B.).

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
DRDavid R. Rawnsley
David R. Rawnsley
JXJiping Xiao
Jiping Xiao
JLJohn S. Lee
John S. Lee
XLXi Liu
Xi Liu
PMPatricia Mericko-Ishizuka
Patricia Mericko-Ishizuka
MKMark L. Kahn
Mark L. Kahn
GATA and Friend of GATA (FOG) form a transcriptional complex that plays a key role in cardiovascular development in both fish and mammals. In the present study we demonstrate that the basic helix-loop-helix transcription factor Atonal homolog 8 (Atoh8) is required for development of the heart in fish but not in mice. Genetic studies reveal that Atoh8 interacts specifically with Gata4 and Fog1 during development of the heart and swim bladder in the fish. Biochemical studies reveal that ATOH8, GATA4, and FOG2 associate in a single complex in vitro. In contrast to fish, ATOH8-deficient mice exhibit normal cardiac development and loss of ATOH8 does not alter cardiac development in Gata4+/− mice. This species difference in the role of ATOH8 is explained in part by LacZ and GFP reporter alleles that reveal restriction of Atoh8 expression to atrial but not ventricular myocardium in the mouse. Our findings identify ATOH8 as a novel regulator of GATA-FOG function that is required for cardiac development in the fish but not the mouse. Whether ATOH8 modulates GATA-FOG function at other sites or in more subtle ways in mammals is not yet known.

1 August 2012 in Journal of Pain Research
Verified
Journal Article
Open access
VKVinayak Kumar
Vinayak Kumar
MAMahal
Mahal
Peer reviewed article authored by (Kumar V, Mahal BA). Read article or submit your manuscript for publishing.

1 July 2020 in International Journal of Cardiology
Verified
Journal Article
Closed access
Saraschandra VallabhajosyulaSaraschandra Vallabhajosyula
Saraschandra Vallabhajosyula
VKVinayak Kumar
Vinayak Kumar
SVSaarwaani Vallabhajosyula
Saarwaani Vallabhajosyula
ASAnna V Subramaniam
Anna V Subramaniam
SPSri Harsha Patlolla
Sri Harsha Patlolla
GBGregory W Barsness
Gregory W Barsness

18 November 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Saraschandra VallabhajosyulaSaraschandra Vallabhajosyula
Saraschandra Vallabhajosyula
LYLina Ya’qoub
Lina Ya’qoub
VKVinayak Kumar
Vinayak Kumar
DVDhiran Verghese
Dhiran Verghese
ASAnna V. Subramaniam
Anna V. Subramaniam
GBGregory W. Barsness
Gregory W. Barsness
Background: There are limited data on acute myocardial infarction with cardiogenic shock (AMI-CS) stratified by chronic kidney disease (CKD) stages. Objective: To assess clinical outcomes in AMI-CS stratified by CKD stages. Methods: A retrospective cohort of AMI-CS during 2005–2016 from the National Inpatient Sample was categorized as no CKD, CKD stage-III (CKD-III), CKD stage-IV (CKD-IV) and end-stage renal disease (ESRD). CKD-I/II were excluded. Outcomes included in-hospital mortality, use of coronary angiography, percutaneous coronary intervention (PCI) and mechanical circulatory support (MCS). We also evaluated acute kidney injury (AKI) and acute hemodialysis in non-ESRD admissions. Results: Of 372,412 AMI-CS admissions, CKD-III, CKD-IV and ESRD comprised 20,380 (5.5%), 7367 (2.0%) and 18,109 (4.9%), respectively. Admissions with CKD were, on average, older, of the White race, bearing Medicare insurance, of a lower socioeconomic stratum, with higher comorbidities, and higher rates of acute organ failure. Compared to the cohort without CKD, CKD-III, CKD-IV and ESRD had lower use of coronary angiography (72.7%, 67.1%, 56.9%, 61.1%), PCI (53.7%, 43.8%, 38.4%, 37.6%) and MCS (47.9%, 38.3%, 33.3%, 34.2%), respectively (all p < 0.001). AKI and acute hemodialysis use increased with increase in CKD stage (no CKD–38.5%, 2.6%; CKD-III–79.1%, 6.5%; CKD-IV–84.3%, 12.3%; p < 0.001). ESRD (adjusted odds ratio [OR] 1.25 [95% confidence interval {CI} 1.21–1.31]; p < 0.001), but not CKD-III (OR 0.72 [95% CI 0.69–0.75); p < 0.001) or CKD-IV (OR 0.82 [95 CI 0.77–0.87] was predictive of in-hospital mortality. Conclusions: CKD/ESRD is associated with lower use of evidence-based therapies. ESRD was an independent predictor of higher in-hospital mortality in AMI-CS.

1 September 2015 in Resuscitation
Verified
Journal Article
Closed access
AKAlexander Z. Katz
Alexander Z. Katz
AGAnne V. Grossestreuer
Anne V. Grossestreuer
DGDavid F. Gaieski
David F. Gaieski
BABenjamin S. Abella
Benjamin S. Abella
VKVinayak Kumar
Vinayak Kumar
JPJeanmarie Perrone
Jeanmarie Perrone

18 April 2013 in Blood
Verified
Journal Article
Open access
PDF file
ZZZhiying Zou
Zhiying Zou
DEDavid R. Enis
David R. Enis
HBHung Bui
Hung Bui
EKEugene Khandros
Eugene Khandros
VKVinayak Kumar
Vinayak Kumar
MKMark L. Kahn
Mark L. Kahn
Key Points The secreted lymphangiogenic protein CCBE1 is essential for fetal but not postnatal erythropoiesis. Loss of CCBE1 impairs erythroblastic island formation and function.